A Dominant-Negative Mutation of Mouse Causes Glaucoma and Is Semi-lethal via LBD1-Mediated Dimerisation

English version České info

Nail-patella syndrome is a human genetic disease caused by an inactivating mutation in one copy of a gene called LMX1B, with the amount of protein produced from the remaining copy of the gene not being enough for normal function. Patients with this disease have malformations of their nails, elbows and kneecaps. Some patients also develop kidney disease and glaucoma. LMX1B controls where and when other genes are expressed and it is important during development. Studies in mice have shown that complete absence of Lmx1b is lethal at birth. In contrast to humans, mice with only one copy of the gene are normal. Here we describe a new mutant mouse, Icst, which has a mutation in Lmx1b that abolishes the ability of the protein to bind near genes that it controls. Mice with one normal and one copy of Lmx1b with the Icst mutation have eye defects and some die shortly after birth probably due to kidney failure. Therefore having one functional and one mutant copy of Lmx1b is more detrimental than having a half dose of functional protein. The Icst mouse is a model of human glaucoma where mutation of the same gene causes glaucoma in humans and mice.

Vyšlo v časopise: A Dominant-Negative Mutation of Mouse Causes Glaucoma and Is Semi-lethal via LBD1-Mediated Dimerisation. PLoS Genet 10(5): e32767. doi:10.1371/journal.pgen.1004359
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004359

Souhrn

Zdroje

1. SweeneyE, FryerA, MountfordR, GreenA, McIntoshI (2003) Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet 40: 153–162.

2. MimiwatiZ, MackeyDA, CraigJE, MackinnonJR, RaitJL, et al. (2006) Nail-patella syndrome and its association with glaucoma: a review of eight families. Br J Ophthalmol 90: 1505–1509.

3. DreyerSD, ZhouG, BaldiniA, WinterpachtA, ZabelB, et al. (1998) Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 19: 47–50.

4. VollrathD, Jaramillo-BabbVL, CloughMV, McIntoshI, ScottKM, et al. (1998) Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome. Hum Mol Genet 7: 1091–1098.

5. McIntoshI, DreyerSD, CloughMV, DunstonJA, EyaidW, et al. (1998) Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet 63: 1651–1658.

6. BongersEM, de WijsIJ, MarcelisC, HoefslootLH, KnoersNV (2008) Identification of entire LMX1B gene deletions in nail patella syndrome: evidence for haploinsufficiency as the main pathogenic mechanism underlying dominant inheritance in man. Eur J Hum Genet 16: 1240–1244.

7. DreyerSD, MorelloR, GermanMS, ZabelB, WinterpachtA, et al. (2000) LMX1B transactivation and expression in nail-patella syndrome. Hum Mol Genet 9: 1067–1074.

8. SatoU, KitanakaS, SekineT, TakahashiS, AshidaA, et al. (2005) Functional characterization of LMX1B mutations associated with nail-patella syndrome. Pediatr Res 57: 783–788.

9. BongersEM, HuysmansFT, LevtchenkoE, de RooyJW, BlickmanJG, et al. (2005) Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy. Eur J Hum Genet 13: 935–946.

10. DunstonJA, LinS, ParkJW, MalbrouxM, McIntoshI (2005) Phenotype severity and genetic variation at the disease locus: an investigation of nail dysplasia in the nail patella syndrome. Ann Hum Genet 69: 1–8.

11. DaiJX, JohnsonRL, DingYQ (2009) Manifold functions of the Nail-Patella Syndrome gene Lmx1b in vertebrate development. Dev Growth Differ 51: 241–250.

12. ChenH, LunY, OvchinnikovD, KokuboH, ObergKC, et al. (1998) Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat Genet 19: 51–55.

13. ChenH, OvchinnikovD, PressmanCL, AulehlaA, LunY, et al. (1998) Multiple calvarial defects in lmx1b mutant mice. Dev Genet 22: 314–320.

14. GuoC, QiuHY, HuangY, ChenH, YangRQ, et al. (2007) Lmx1b is essential for Fgf8 and Wnt1 expression in the isthmic organizer during tectum and cerebellum development in mice. Development 134: 317–325.

15. PressmanCL, ChenH, JohnsonRL (2000) LMX1B, a LIM homeodomain class transcription factor, is necessary for normal development of multiple tissues in the anterior segment of the murine eye. Genesis 26: 15–25.

16. LiuP, JohnsonRL (2010) Lmx1b is required for murine trabecular meshwork formation and for maintenance of corneal transparency. Dev Dyn 239: 2161–2171.

17. EndeleS, KleinS, RichterS, MolterT, AmannK, et al. (2007) Renal phenotype in heterozygous Lmx1b knockout mice (Lmx1b+/−) after unilateral nephrectomy. Transgenic Res 16: 723–729.

18. ThaungC, WestK, ClarkBJ, McKieL, MorganJE, et al. (2002) Novel ENU-induced eye mutations in the mouse: models for human eye disease. Hum Mol Genet 11: 755–767.

19. KeaneTM, GoodstadtL, DanecekP, WhiteMA, WongK, et al. (2011) Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477: 289–294.

20. WilsonDS, GuentherB, DesplanC, KuriyanJ (1995) High resolution crystal structure of a paired (Pax) class cooperative homeodomain dimer on DNA. Cell 82: 709–719.

21. MorelloR, ZhouG, DreyerSD, HarveySJ, NinomiyaY, et al. (2001) Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome. Nat Genet 27: 205–208.

22. DunstonJA, HamlingtonJD, ZaveriJ, SweeneyE, SibbringJ, et al. (2004) The human LMX1B gene: transcription unit, promoter, and pathogenic mutations. Genomics 84: 565–576.

23. QuigleyHA (2011) Glaucoma. Lancet 377: 1367–1377.

24. RohrC, PrestelJ, HeidetL, HosserH, KrizW, et al. (2002) The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest 109: 1073–1082.

25. MinerJH, MorelloR, AndrewsKL, LiC, AntignacC, et al. (2002) Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation. J Clin Invest 109: 1065–1072.

26. JurataLW, GillGN (1997) Functional analysis of the nuclear LIM domain interactor NLI. Mol Cell Biol 17: 5688–5698.

27. JurataLW, PfaffSL, GillGN (1998) The nuclear LIM domain interactor NLI mediates homo- and heterodimerization of LIM domain transcription factors. J Biol Chem 273: 3152–3157.

28. HobertO, WestphalH (2000) Functions of LIM-homeobox genes. Trends Genet 16: 75–83.

29. MilnerJ, MedcalfEA (1991) Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65: 765–774.

30. WillisA, JungEJ, WakefieldT, ChenX (2004) Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Oncogene 23: 2330–2338.

31. AramayoR, ShermanMB, BrownlessK, LurzR, OkorokovAL, et al. (2011) Quaternary structure of the specific p53-DNA complex reveals the mechanism of p53 mutant dominance. Nucleic Acids Res 39: 8960–8971.

32. IsodaK, RothS, Nusslein-VolhardC (1992) The functional domains of the Drosophila morphogen dorsal: evidence from the analysis of mutants. Genes Dev 6: 619–630.

33. LeeD, CrossSH, StrunkKE, MorganJE, BaileyCL, et al. (2004) Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor. Mamm Genome 15: 525–536.

34. MariniM, BongersEM, CusanoR, Di DucaM, SeriM, et al. (2003) Confirmation of CLIM2/LMX1B interaction by yeast two-hybrid screening and analysis of its involvement in nail-patella syndrome. Int J Mol Med 12: 79–82.

35. SuleimanH, HeudoblerD, RaschtaAS, ZhaoY, ZhaoQ, et al. (2007) The podocyte-specific inactivation of Lmx1b, Ldb1 and E2a yields new insight into a transcriptional network in podocytes. Dev Biol 304: 701–712.

36. AsbreukCH, VogelaarCF, HellemonsA, SmidtMP, BurbachJP (2002) CNS expression pattern of Lmx1b and coexpression with ptx genes suggest functional cooperativity in the development of forebrain motor control systems. Mol Cell Neurosci 21: 410–420.

37. GermanMS, WangJ, ChadwickRB, RutterWJ (1992) Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev 6: 2165–2176.

38. JohnsonJD, ZhangW, RudnickA, RutterWJ, GermanMS (1997) Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the LIM2 domain determines specificity. Mol Cell Biol 17: 3488–3496.

39. RaggeNK, BrownAG, PoloschekCM, LorenzB, HendersonRA, et al. (2005) Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet 76: 1008–1022.

40. IsojimaT, HaritaY, FuruyamaM, SugawaraN, IshizukaK, et al. (2013) LMX1B mutation with residual transcriptional activity as a cause of isolated glomerulopathy. Nephrol Dial Transplant 29: 81–88.

41. BoyerO, WoernerS, YangF, OakeleyEJ, LinghuB, et al. (2013) LMX1B mutations cause hereditary FSGS without extrarenal involvement. J Am Soc Nephrol 24: 1216–1222.

42. ParkS, JamshidiY, VaideanuD, Bitner-GlindziczM, FraserS, et al. (2009) Genetic risk for primary open-angle glaucoma determined by LMX1B haplotypes. Invest Ophthalmol Vis Sci 50: 1522–1530.

43. MabuchiF, AiharaM, MackeyMR, LindseyJD, WeinrebRN (2004) Regional optic nerve damage in experimental mouse glaucoma. Invest Ophthalmol Vis Sci 45: 4352–4358.

44. DaiY, LindseyJD, Duong-PolkX, NguyenD, HoferA, et al. (2009) Outflow facility in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci 50: 5749–5753.

45. SenatorovV, MalyukovaI, FarissR, WawrousekEF, SwaminathanS, et al. (2006) Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice. J Neurosci 26: 11903–11914.

46. ZhouY, GrinchukO, TomarevSI (2008) Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest Ophthalmol Vis Sci 49: 1932–1939.

47. ZodeGS, KuehnMH, NishimuraDY, SearbyCC, MohanK, et al. (2011) Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest 121: 3542–3553.

48. Smith RS, John SW, Nishina PM, Sundberg JP, editors (2002) Systematic Evaluation of the Mouse Eye: Anatomy, Pathology and Biomethods. Boca Raton: CRC Press.

49. HealyE, JordanSA, BuddPS, SuffolkR, ReesJL, et al. (2001) Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet 10: 2397–2402.

50. HuCH, McStayB, JeongSW, ReederRH (1994) xUBF, an RNA polymerase I transcription factor, binds crossover DNA with low sequence specificity. Mol Cell Biol 14: 2871–2882.

51. StudierFW, RosenbergAH, DunnJJ, DubendorffJW (1990) Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185: 60–89.

52. CrowYJ, LeitchA, HaywardBE, GarnerA, ParmarR, et al. (2006) Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 38: 910–916.

53. GloecknerCJ, BoldtK, SchumacherA, RoepmanR, UeffingM (2007) A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7: 4228–4234.

54. CrossSH, McKieL, WestK, CoghillEL, FavorJ, et al. (2011) The Opdc missense mutation of Pax2 has a milder than loss-of-function phenotype. Hum Mol Genet 20: 223–234.

55. JohnSW, HagamanJR, MacTaggartTE, PengL, SmithesO (1997) Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci 38: 249–253.

56. SavinovaOV, SugiyamaF, MartinJE, TomarevSI, PaigenBJ, et al. (2001) Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet 2: 12.

57. LibbyRT, LiY, SavinovaOV, BarterJ, SmithRS, et al. (2005) Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 1: 17–26.

58. JurataLW, KennyDA, GillGN (1996) Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc Natl Acad Sci U S A 93: 11693–11698.

59. AndersonMG, LibbyRT, MaoM, CosmaIM, WilsonLA, et al. (2006) Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol 4: 20.